Literature DB >> 33218385

Anesthesia and Perioperative Considerations for Patients With Myasthenia Gravis.

Shawn Collins1, Howard Roberts2, Ian Hewer3.   

Abstract

Patients with neuromuscular diseases such as myasthenia gravis can present as complicated anesthetic cases. This article reviews anesthetic considerations for optimal perioperative care of patients with myasthenia gravis. The pathophysiology of myasthenia gravis, cholinergic and myasthenic crises, and perioperative management are discussed; this includes the pharmacology of acetylcholinesterase inhibitors vs sugammadex, extubation criteria, pain management, and risk factors for postoperative myasthenic crisis. Anesthesia recommendations include reversal of nondepolarizing neuromuscular blockade agents with sugammadex, obtaining sufficient spontaneous breathing with absolutely no residual curarization before extubation, limited use of opioids and sedatives, avoidance of routine admission to the intensive care unit, and consideration of peripheral nerve blocks for adjunct pain control.
Copyright © by the American Association of Nurse Anesthetists.

Entities:  

Keywords:  Anesthesia; myasthenia crisis; myasthenia gravis; postoperative management; risk factors

Mesh:

Year:  2020        PMID: 33218385

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  3 in total

1.  Open thoracoabdominal aortic aneurysm repair in a patient with myasthenia gravis.

Authors:  Kyokun Uehara; Yasue Fujiwara; Manabu Morishima; Atsushi Iwakura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

2.  Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report.

Authors:  Daniel Haddad; Adeeb J Hanna; Lori Russo
Journal:  Cureus       Date:  2022-07-27

Review 3.  Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.

Authors:  Luuk R van den Bersselaar; Madelief Gubbels; Sheila Riazi; Luc Heytens; Heinz Jungbluth; Nicol C Voermans; Marc M J Snoeck
Journal:  Can J Anaesth       Date:  2022-03-23       Impact factor: 6.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.